Corcept Therapeutics up 26% on new Korlym patent Seeking Alpha
Corcept Therapeutics (CORT +25.6%) is up on almost a 5x surge in volume in response to a reported new U.S. patent covering Korlym (mifepristone).
Corcept Therapeutics up 26% on new Korlym patent Seeking Alpha
Corcept Therapeutics (CORT +25.6%) is up on almost a 5x surge in volume in response to a reported new U.S. patent covering Korlym (mifepristone).